Evidence map›Paper›PMID 30200880›Full record

ArticleBMC cardiovascular disorders2018

Value of the fT3/fT4 ratio and its combination with the GRACE risk score in predicting the prognosis in euthyroid patients with acute myocardial infarction undergoing percutaneous coronary intervention: a prospective cohort study.

Tongtong Yu, Chunyang Tian, Jia Song, Dongxu He, Jiake Wu, Zongyu Wen, Zhijun Sun, Zhaoqing Sun

Open access · goldAbstract readComparative Study
In one paragraph

Article in BMC cardiovascular disorders, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Observational
  19. Observational
  20. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Tongtong YuDepartment of Cardiology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, People's Republic of China.
Chunyang TianDepartment of Cardiology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, People's Republic of China.
Jia SongDepartment of Cardiology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, People's Republic of China.
Dongxu HeDepartment of Cardiology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, People's Republic of China.
Jiake WuDepartment of Cardiology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, People's Republic of China.
Zongyu WenDepartment of Cardiology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, People's Republic of China.
Zhijun SunDepartment of Cardiology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, People's Republic of China.
Zhaoqing SunDepartment of Cardiology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, People's Republic of China. sunzhaoqing@vip.163.com.ORCID 0000-0002-1608-7396
China Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThyroid hormones deeply influence the cardiovascular system; however, the association between the fT3/fT4 ratio and the clinical outcome in euthyroid patients with acute myocardial infarction (AMI) undergoing percutaneous coronary intervention (PCI) is not well defined. Therefore, the present study aimed to assess the prognostic performance of the fT3/fT4 ratio in predicting the long-term prognosis in euthyroid patients with AMI undergoing PCI.

methodsIn a prospective cohort study with a 1-year follow-up, according to the clinical end point, 953 euthyroid individuals (61.0 ± 11.6; female, 25.8%) were divided into two groups: (1) the survival group (n = 915) and (2) the death group (n = 38).

resultsAccording to Cox regression multivariate analysis, fT4 (HR: 1.249, 95% CI: 1.053-1.480, p = 0.010) and the fT3/fT4 ratio (HR: 3.546, 95% CI: 1.705-7.377, p = 0.001) were associated with an increased risk of 1-year all-cause mortality. The prognostic performance of the fT3/fT4 ratio was similar to the Global Registry of Acute Coronary Events (GRACE) score in predicting 1-year all-cause mortality (C-statistic: z = 0.261, p = 0.794; IDI: -0.017, p = 0.452; NRI: -0.049, p = 0.766), but better than fT4 (C-statistic: z = 2.438, p = 0.015; IDI: 0.053, p = 0.002; NRI: 0.656, p < 0.001). The fT3/fT4 ratio also significantly improved the prognostic performance of the GRACE score (GRACE score vs GRACE score + fT3/fT4 ratio: C-statistic: z = 2.116, p = 0.034; IDI: 0.0415, p = 0.007; NRI: 0.614, p < 0.001).

conclusionsIn euthyroid patients with AMI undergoing PCI, the fT3/fT4 ratio was an independent predictor of 1-year all-cause mortality. Its prognostic performance was similar to the GRACE score, and also improved its prognostic performance (GRACE score vs GRACE score + fT3/fT4 ratio).

Indexed as

Decision Support TechniquesPercutaneous Coronary InterventionThyroid Function TestsAgedBiomarkersFemaleHumansMaleMiddle AgedMyocardial InfarctionPredictive Value of TestsProspective StudiesRisk AssessmentRisk FactorsThyroxineTime FactorsBiomarkersThyroxineTriiodothyronineAcute myocardial infarctionfT3/fT4 ratioGRACE risk scorePercutaneous coronary intervention

Identifiers

PMID30200880
PMCPMC6131820
OpenAlexW2890994527

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.